Mindy Magee - Concepedia

Author

Mindy Magee

GlaxoSmithKline (United States)

Also Known As

M H Magee, M. H. Magee, Mindy H Magee, Mindy H. Magee, Mindy He Magee, Mindy Magee, Mindy Magee (514734)

Publications

779

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United States)GlaxoSmithKline (United Kingdom)Gilead Sciences (United States)Research Triangle Park Foundation University at Buffalo, State University of New York

About

Mindy Magee is an author at GlaxoSmithKline (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	188
2	Immunology	2	2	69
3	Engineering	1	1	10
4	Diabetes	1	1	43
5	Pathology	1	1	43

Mindy Magee

Publications

666

Citations

H-Index

Page 1

	Year	Citations
Prednisolone Pharmacokinetics and Pharmacodynamics in Relation to Sex and Race Mindy Magee, Robert A. Blum, Christian D. Lates, The Journal of Clinical Pharmacology	2001	122
GSK2881078, a SARM, Produces Dose-Dependent Increases in Lean Mass in Healthy Older Men and Women David Neil, Richard V. Clark, Mindy Magee, The Journal of Clinical Endocrinology & Metabolism	2018	69
Safety, pharmacokinetics and pharmacological effects of the selective androgen receptor modulator, GSK2881078, in healthy men and postmenopausal women Richard V. Clark, Ann C. Walker, Susan Andrews, British Journal of Clinical Pharmacology	2017	62
A Randomized Phase 2 Study of an Anti–Amyloid β Monoclonal Antibody in Geographic Atrophy Secondary to Age-Related Macular Degeneration Philip J. Rosenfeld, Brian B. Berger, Elias Reichel, Ophthalmology Retina Ocular DiseaseAlzheimer's DiseaseOphthalmologyAge-related DiseasesImmunology	2018	54
Pharmacokinetic/pharmacodynamic model for prednisolone inhibition of whole blood lymphocyte proliferation Mindy Magee, Robert A. Blum, Christian D. Lates, British Journal of Clinical Pharmacology	2002	44
Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, in Diabetic Macular Edema Giovanni Staurenghi, Ye Li, Mindy Magee, Ophthalmology Metabolic SyndromeOphthalmologyMedicineDiabetesPathology	2015	43
Potential for Pharmacokinetic Interactions Between Ambrisentan and Cyclosporine Rebecca Spence, Arun Mandagere, Duncan Richards, Clinical Pharmacology & Therapeutics	2010	40
Pharmacokinetic and pharmacodynamic interactions between diltiazem and methylprednisolone in healthy volunteers Brent M. Booker, Mindy Magee, Robert A. Blum, Clinical Pharmacology & Therapeutics	2002	33
Effect of Ketoconazole on the Pharmacokinetic Profile of Ambrisentan Duncan Richards, Gennyne Walker, Arun Mandagere, The Journal of Clinical Pharmacology Medicinal ChemistryPharmacological StudyPharmacokinetic ProfileMedicinePhysiology	2009	31
Effects of Rifampicin (Rifampin) on the Pharmacokinetics and Safety of Ambrisentan in Healthy Subjects Brooke C. Harrison, Mindy Magee, Arun Mandagere, Clinical Drug Investigation Drug SafetyHealthy SubjectsPharmacological StudyPharmacologyClinical Pharmacology	2010	23

Page 1